Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Revenue: 2011-2025

Historic Revenue for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $113.7 million.

  • Mimedx Group's Revenue rose 35.30% to $113.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.4 million, marking a year-over-year increase of 14.77%. This contributed to the annual value of $348.9 million for FY2024, which is 8.52% up from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's Revenue is $113.7 million, which was up 15.33% from $98.6 million recorded in Q2 2025.
  • Mimedx Group's 5-year Revenue high stood at $113.7 million for Q3 2025, and its period low was $50.8 million during Q4 2021.
  • Over the past 3 years, Mimedx Group's median Revenue value was $86.8 million (recorded in 2023), while the average stood at $88.3 million.
  • Per our database at Business Quant, Mimedx Group's Revenue dropped by 25.87% in 2021 and then surged by 46.37% in 2022.
  • Over the past 5 years, Mimedx Group's Revenue (Quarterly) stood at $50.8 million in 2021, then spiked by 46.37% to $74.4 million in 2022, then rose by 16.75% to $86.8 million in 2023, then rose by 7.00% to $92.9 million in 2024, then surged by 35.30% to $113.7 million in 2025.
  • Its Revenue was $113.7 million in Q3 2025, compared to $98.6 million in Q2 2025 and $88.2 million in Q1 2025.